Exchange: NASDAQ·Updated 05:32 AM EDT
TWST logo

TWSTTwist Bioscience Corp

$102.90
$0.02
(0.02%)
Pre-Market
Prev Close $102.88
EarningsAug 3
Mkt Cap$6.13B
Vol91.00
News
all
press releases
Cathie Wood Goes All-In On SpaceX Debut, Dumps Rocket Lab Stock The Same Day
ARK doubled down on SpaceX while cutting its Rocket Lab position, a stock SpaceX's own S-1 names as a direct competitor.
Stocktwits
News Placeholder
More News
News Placeholder
Twist Bioscience Director Sold 12,000 Shares. Here's What That Means for Investors.
Key Points12,000 shares were exercised from options and sold for a total of ~$673,000 on May 12, 2026...
Nasdaq News: Markets
News Placeholder
Twist Bioscience (TWST) Surges 9.3%: Is This an Indication of Further Gains?
Twist Bioscience (TWST) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks
News Placeholder
Is Cathie Wood Making Room For SpaceX? ARK Funds Dump Over $200M Across 20 Stocks Ahead Of Mega IPO
ARK Investment Management sold shares in Teradyne, Twist Bioscience, Iridium Communications, and Robinhood Markets, among other companies.
Stocktwits
News Placeholder
Twist Bioscience's Chief Legal Officer Sold Over 14,000 Company Shares. What Does That Mean for Investors?
Key PointsDennis Cho sold 14,205 shares on May 29, 2026, for a total transaction value of ~$991,000, at a reported price of $69.75 per share...
Nasdaq News: Markets
News Placeholder
Twist Biosciences' (TWST) CEO Sold 16,000 Shares for $1.1 Million
Key Points16,470 common shares were exercised via options and disposed in the open market for a transaction value of ~$1.12 million on May 28, 2026...
Nasdaq News: Markets
News Placeholder
3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2026
Genomics and synthetic biology are reshaping healthcare, with growing demand for precision medicine spotlighting stocks like PACB, MYGN and TWST.
Zacks
News Placeholder
Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference
Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience and Adam Laponis, CFO of Twist Bioscience will present at the William Blair 46th Annual Growth Stock Conference on Tuesday...
Business Wire
News Placeholder
Twist Bioscience Corporation (TWST) Announces Q2 2026 Financial Results
Twist Bioscience Corporation (TWST) Announces Q2 2026 Financial Results...
Yahoo! Finance: News
News Placeholder
These Analysts Boost Their Forecasts On Twist Bioscience After Q2 Results
Twist Bioscience Corp (TWST) reported Q2 loss but exceeded sales guidance. CEO expects profitability and raised FY sales guidance. Analysts raise price targets.read more...
Benzinga
<
1
2
...
>

Advertisement|Remove ads.